SG/CALL/MODERNA/110/0.1/17.01.25 Stock

Warrant

DE000SV6CUS5

Market Closed - Deutsche Boerse AG 03:50:21 2024-07-05 pm EDT
2.4 EUR -0.41% Intraday chart for SG/CALL/MODERNA/110/0.1/17.01.25
Current month-0.83%
1 month-53.40%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 2.4 -0.41%
24-07-04 2.41 +6.64%
24-07-03 2.26 -2.16%
24-07-02 2.31 0.00%
24-07-01 2.31 -4.55%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 03:50 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SV6CUS
ISINDE000SV6CUS5
Date issued 2023-05-15
Strike 110 $
Maturity 2025-01-17 (194 Days)
Parity 10 : 1
Emission price 4.34
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.37
Lowest since issue 0.76
Spread 0.02
Spread %0.83%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
118.3 USD
Average target price
145.9 USD
Spread / Average Target
+23.27%
Consensus